Etoricoxib
COMPOSITION
Torcox™ 60 Tablet : Each film coated tablet contains Etoricoxib INN 60 mg.
Torcox™ 90 Tablet : Each film coated tablet contains Etoricoxib INN 90 mg.
Torcox™ 120 Tablet : Each film coated tablet contains Etoricoxib INN 120 mg.
INDICATION
Torcox™ (Etoricoxib) is indicated for relief of pain and inflammation in -• Osteoarthritis
• Rheumatoid arthritis
• Ankylosing spondylitis
• Other chronic musculoskeletal disorders
• Acute gout
• Primary dysmenorrhoea &
• Dental pain
DOSE AND ADMINISTRATION
Pain and inflammation in Osteoarthritis:
• Child 16-17 years: 30 mg once daily, increased if necessary to 60 mg once daily
• Adult: 30 mg once daily, increased if necessary to 60 mg once daily. Pain and inflammation in rheumatoid arthritis & Ankylosing spondylitis:
• Child 16-17 years: 60 mg once daily, increased if necessary to 90 mg once daily.
Adult: 60 mg once daily, increased if necessary to 90 mg once daily.
Acute gout:
• Child 16-17 years: 120 mg once daily for maximum 8 days
• Adult: 120 mg once daily for maximum 8 days
Dental pain:
• 90-120 mg once daily for maximum 8 days.
Primary dysmenorrhoea
• 120 mg once daily for maximum 8 days
or as directed by the physician
Empagliflozin + Metformin
Composition
Glifomet Tablet: Each film coated tablet contains Empagliflozin INN 5 mg and Metformin Hydrochloride BP 500 mg.
Indication
Glifomet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type
2 diabetes mellitus when treatment with both Empagliflozin and Metformin Hydrochloride is
inappropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2
diabetes mellitus and established cardiovascular disease
Dose & Administration
• The starting dose of Glifomet should be based on the patient's current regimen.
• Take twice daily with meals, with gradual dose escalation to reduce the gastrointestinal side effects due to Metformin Hydrochloride.
• The maximum recommended dose is 12.5 mg empagliflozin /1 000 mg metformin hydrochloride twice daily.
• Assess renal function before initiating Glifomet. Do not initiate or continue Glifomet if creatinine levels are greater than or equal to 1.5 mg /dL for males or 1.4 mg /dL for females or if eGFR is below 45 mL /min II.73 m2 or as directed by the physician.
Esomeprazole
Composition
Esotac20 Capsule: Each delayed release capsule contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg.
Esotac40 Capsule: Each delayed release capsule contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 40 mg.
Esotac20 Tablet: Each enteric coated tablet contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg.
Esotac40 Tablet: Each enteric coated tablet contains Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 40 mg.
Indication
1. Healing of erosive esophagitis
2. Long-term management of esophagitis
3. Symptomatic gastroesophageal reflux disease
4. H. pylori eradication for the treatment of duodenal ulcer (Triple therapy with Esomeprazole,
clarithromycin and amoxicillin)
Dose and Administration
Healing of erosive Esophagitis: 20 mg or 40 mg once daily for 4-8 weeks. For those patients who have not healed after 4-8 weeks of treatment, an additional 4-8 weeks course of Esomeprazole may be considered.Long-term management of esophagitis: 20 mg once daily. Symptomatic gastroesophageal reflux disease: 20 mg once daily for 4 weeks.
H. pylori eradication for the treatment of duodenal ulcer (Triple therapy): 20 mg Esomeprazole once daily with 500 mg clarithromycin twice daily and 1g amoxicillin twice daily for 7-10 days or as directed by the physician